Pelthos Therapeutics Inc. (PTHS) is a publicly traded Healthcare sector company. As of November 12, 2026, PTHS trades at $9.39 with a market cap of $34.99M and a P/E ratio of -0.94. PTHS moved +0.00% today. Year to date, PTHS is -69.69%; over the trailing twelve months it is -72.69%. Its 52-week range spans $8.72 to $54.29. Analyst consensus is strong buy with an average price target of $49.50. Rallies surfaces PTHS's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks PTHS insider trades, Form 4 activity, executive purchases, executive sales, shares, prices, and transaction dates when available.
| Metric | Value |
|---|---|
| Price | $9.39 |
| Market Cap | $34.99M |
| P/E Ratio | -0.94 |
| EPS | $-23.04 |
| Dividend Yield | 0.00% |
| 52-Week High | $54.29 |
| 52-Week Low | $8.72 |
| Volume | 0 |
| Avg Volume | 0 |
| Revenue (TTM) | $16.80M |
| Net Income | $-43.32M |
| Gross Margin | 76.25% |
6 analysts cover PTHS: 0 strong buy, 6 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $49.50.